Proton pump inhibitors and cancers: A hazardous association?
Authors:
- 1 April 2020
- journal article
- review article
- Published by Elsevier in Bulletin du Cancer
- Vol. 107 (4) , 458-464
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumorsCancer Chemotherapy and Pharmacology, 2013
- Accumulating Evidence for a Drug–Drug Interaction Between Methotrexate and Proton Pump InhibitorsThe Oncologist, 2012
- Effect of a proton pump inhibitor on the pharmacokinetics of imatinibBritish Journal of Clinical Pharmacology, 2009
- Proton pump inhibitors and risk of gastric cancer: a population-based cohort studyBritish Journal of Cancer, 2009
- Overprescribing proton pump inhibitorsBMJ, 2008
- Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosisGut, 2007
- Proton pump inhibitors and gastric neoplasia: Figure 1Gut, 2006
- Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UKGut, 2006
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004
- Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemiaAPMIS, 2002